Data / Public companies / Florida / Pharmaceutical preparations
Pharmaceutical preparations companies in Florida: 31 that file annual reports with the SEC
31 companies that file annual reports with the SEC have a business address in Florida and the industry code SIC 2834 (Pharmaceutical preparations), in the SEC Financial Statement Data Sets filed through September 30, 2026. 16 report revenue, a combined $1.37 billion. 9.7% of the 31 that report net income show a profit. The largest by revenue is Opko Health, Inc. ($606.9 million).
SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.
- 2834SIC code
- 31Companies with an annual report in the data
- 16Companies that report revenue
- $1.37 billionCombined revenue
- $1.3 millionMedian revenue
- 3 of 31 (9.7%)Reported a net profit
- $4.49 billionCombined total assets
- 3Large accelerated filers
- June 18, 2026Newest annual report filed
Largest by revenue
Latest fiscal year, from each company's annual report. Each name links to the company's page.
| Company | Business address | Revenue | Net income | Total assets | Revenue change |
|---|---|---|---|---|---|
| Opko Health, Inc. | Miami, FL | $606.9 million | $-225,680,000 | $1.93 billion | -14.9% |
| Catalyst Pharmaceuticals, Inc. | Coral Gables, FL | $589 million | $214.3 million | $1.10 billion | 19.8% |
| Fortress Biotech, Inc. | Bay Harbor Islands, FL | $63.3 million | $6.8 million | $185.5 million | 9.7% |
| Lftd Partners Inc. | Jacksonville, FL | $36.9 million | $-24,858,678 | $19.3 million | -1.1% |
| Sunshine Biopharma Inc. | Fort Lauderdale, FL | $36.3 million | $-5,975,352 | $30.1 million | 4.1% |
| Earth Science Tech, Inc. | Miami, FL | $35.7 million | $3.6 million | $9 million | 7.8% |
| Therapeuticsmd, Inc. | Boca Raton, FL | $3 million | $-569,000 | $37.7 million | 71.6% |
| Avenue Therapeutics, Inc. | Bay Harbor Islands, FL | $1.4 million | $-2,909,000 | $2.9 million | Not listed |
| Longeveron Inc. | Miami, FL | $1.2 million | $-22,704,000 | $10.3 million | -49.9% |
| Polomar Health Services, Inc. | Palm Harbor, FL | $648,231 | $-10,701,105 | $390,043 | 1,002% |
| Silo Pharma, Inc. | Sarasota, FL | $72,102 | $-4,227,698 | $7.6 million | 0% |
| HCW Biologics Inc. | Miramar, FL | $54,232 | $-7,959,709 | $24.5 million | -97.9% |
| Gridai Technologies Corp. | Boca Raton, FL | $36,251 | $-6,392,654 | $48.6 million | Not listed |
| Jupiter Neurosciences, Inc. | Jupiter, FL | $21,796 | $-8,644,897 | $5.6 million | Not listed |
| Aspire Biopharma Holdings, Inc. | Estero, FL | $6,202 | $-24,480,848 | $1.3 million | Not listed |
| Alaunos Therapeutics, Inc. | Fort Lauderdale, FL | $5,000 | $-4,176,000 | $3 million | -50% |
Largest by total assets
| Company | Business address | Revenue | Net income | Total assets |
|---|---|---|---|---|
| Opko Health, Inc. | Miami, FL | $606.9 million | $-225,680,000 | $1.93 billion |
| Catalyst Pharmaceuticals, Inc. | Coral Gables, FL | $589 million | $214.3 million | $1.10 billion |
| Summit Therapeutics Inc. | Miami, FL | Not listed | $-1,079,586,000 | $751.2 million |
| Fortress Biotech, Inc. | Bay Harbor Islands, FL | $63.3 million | $6.8 million | $185.5 million |
| Relmada Therapeutics, Inc. | Coral Gables, FL | Not listed | $-57,385,163 | $94 million |
| Pasithea Therapeutics Corp. | Miami Beach, FL | Not listed | $-20,427,683 | $60.2 million |
| Gridai Technologies Corp. | Boca Raton, FL | $36,251 | $-6,392,654 | $48.6 million |
| Akari Therapeutics PLC | Tampa, FL | Not listed | $-17,298,000 | $47.9 million |
| Therapeuticsmd, Inc. | Boca Raton, FL | $3 million | $-569,000 | $37.7 million |
| Sunshine Biopharma Inc. | Fort Lauderdale, FL | $36.3 million | $-5,975,352 | $30.1 million |
| Veru Inc. | Miami, FL | Not listed | $-22,726,279 | $29.8 million |
| Tuhura Biosciences, Inc. | Tampa, FL | Not listed | $-30,051,977 | $27.4 million |
| HCW Biologics Inc. | Miramar, FL | $54,232 | $-7,959,709 | $24.5 million |
| Lftd Partners Inc. | Jacksonville, FL | $36.9 million | $-24,858,678 | $19.3 million |
| Lixte Biotechnology Holdings, Inc. | Boca Raton, FL | Not listed | $-6,078,593 | $12.7 million |
Companies by size of revenue
Companies that report revenue, by the revenue in their latest annual report.
| Revenue | Companies | Share |
|---|---|---|
| Under $10 million | 10 | 62.5% |
| $10 million to $100 million | 4 | 25% |
| $100 million to $1 billion | 2 | 12.5% |
Cities with the most companies
By city of the business address.
| City | Companies | Share |
|---|---|---|
| Miami | 7 | 22.6% |
| Boca Raton | 3 | 9.7% |
| Tampa | 3 | 9.7% |
| Bay Harbor Islands | 2 | 6.5% |
| Coral Gables | 2 | 6.5% |
| Fort Lauderdale | 2 | 6.5% |
| Estero | 1 | 3.2% |
| Jacksonville | 1 | 3.2% |
| Jupiter | 1 | 3.2% |
| Lakewood Ranch | 1 | 3.2% |
| Lighthouse Point | 1 | 3.2% |
| Miami Beach | 1 | 3.2% |
| Miramar | 1 | 3.2% |
| Naples | 1 | 3.2% |
| Palm Harbor | 1 | 3.2% |
Newest annual reports
By the date the company filed its latest annual report with the SEC.
| Company | Filed | Fiscal year ended | Form | Revenue |
|---|---|---|---|---|
| Earth Science Tech, Inc. | June 18, 2026 | March 31, 2026 | 10-K | $35.7 million |
| Polomar Health Services, Inc. | May 6, 2026 | December 31, 2025 | 10-K | $648,231 |
| Gridai Technologies Corp. | May 1, 2026 | December 31, 2025 | 10-K | $36,251 |
| CDT Equity Inc. | April 15, 2026 | December 31, 2025 | 10-K | Not listed |
| Sunshine Biopharma Inc. | April 3, 2026 | December 31, 2025 | 10-K | $36.3 million |
| Jupiter Neurosciences, Inc. | April 1, 2026 | December 31, 2025 | 10-K | $21,796 |
| Lftd Partners Inc. | April 1, 2026 | December 31, 2025 | 10-K | $36.9 million |
| Cadrenal Therapeutics, Inc. | March 31, 2026 | December 31, 2025 | 10-K | Not listed |
| Mira Pharmaceuticals, Inc. | March 31, 2026 | December 31, 2025 | 10-K | Not listed |
| Zyversa Therapeutics, Inc. | March 31, 2026 | December 31, 2025 | 10-K | Not listed |
| HCW Biologics Inc. | March 31, 2026 | December 31, 2025 | 10-K | $54,232 |
| Tuhura Biosciences, Inc. | March 31, 2026 | December 31, 2025 | 10-K | Not listed |
Filer category
The SEC's size class for the company when it filed.
| Category | Companies | Share |
|---|---|---|
| Non-accelerated filer | 28 | 90.3% |
| Large accelerated filer | 3 | 9.7% |
Updated September 30, 2026. Read from SEC Financial Statement Data Sets (sec.gov). Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.